Journal of drug targeting

Treating colorectal cancer by targeting cell changes, cancer stem cells, and alternative cell death to overcome drug resistance

Updated

Abstract

Colorectal cancer may benefit from targeting multiple regulated cell death pathways to overcome chemoresistance.

  • Epithelial-mesenchymal transition, colorectal cancer stem cells, and apoptosis evasion are associated with chemoresistance in colorectal cancer.
  • Natural and synthetic compounds can potentially modulate cell death pathways such as ferroptosis, cuproptosis, paraptosis, and autophagy.
  • Key regulatory pathways include Wnt/β-catenin, TGF-β, JAK2/STAT3/GPX4, and p38α, which may influence treatment efficacy.
  • Compounds like neferine, ajoene, and curcumin analogs, along with drugs like 5-FU and oxaliplatin, are linked to the modulation of EMT and chemoresistance.
  • Targeting multiple aspects of EMT, cancer stem cell maintenance, and chemoresistance could represent a new therapeutic approach for colorectal cancer.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free